Suppr超能文献

分析在大鼠肝 9000g 上清液中的astrapterocarpan 代谢产物。

Profiling the metabolites of astrapterocarpan in rat hepatic 9000g supernatant.

机构信息

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 10000, China; School of Pharmaceutical Sciences, Guizhou University, Guiyang 550000, China.

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 10000, China.

出版信息

Chin J Nat Med. 2019 Nov;17(11):842-857. doi: 10.1016/S1875-5364(19)30102-5.

Abstract

Astrapterocarpan (AP) is a bioactive constituent of Astragali Radix and was selected as a model compound for investigating the in vitro metabolism of pterocarpans in this study. Its in vitro metabolism was conducted by incubation with rat hepatic 9000g supernatant (S9) in the presence of an NADPH-generating system. At first, four compounds were isolated and their structures were elucidated as 6a-hydroxy-AP (M1), astrametabolin I [M2, 1a-hydroxy-9, 10-dimethoxy-pterocarp-1(2), 4-diene-3-one], 9-demethyl-AP (M3, nissolin) and 4-methoxy-astraisoflavan (M4, 7, 2'dihydroxy-4, 3', 4'-trimethoxy-isoflavan) on the basis of NMR data, respectively. Among them, M1, M2 and M4 were new compounds. Next, the metabolite profile of AP in rat hepatic S9 was obtained via HPLC-DAD-ESI-IT-TOF-MS, and 40 new metabolites were tentatively identified. These newly identified metabolites included 9 monohydroxylated metabolites, 1 demethylated metabolite, 7 demethylated and monohydroxylated metabolites, 4 dihydroxylated metabolites, 1 hydration metabolite, 1 didemethylated metabolite, 2 glucosylated metabolites, 1 monohydroxylated and dehydrogenated metabolite, 2 monohydroxylated and demethylated and dehydrogenated metabolites, 2 dimerized metabolites, 3 dimerized and monohydroxylated metabolites, 2 dimerized and didemethylated metabolites, and 5 dimerized and demethylated metabolites. Finally, the major metabolic reactions of AP in rat hepatic S9 were summarized and found to be hydroxylation, demethylation, dimerization, hydration, and dehydrogenation. More importantly, the biotransformation from AP to M2 and the dimerization of AP by incubation with hepatic S9 were reported for the first time. In conclusion, this is the first report on the metabolism of a pure pterocarpan in animal tissues, and these findings will provide a solid basis for further studies on the metabolism of other pterocarpans.

摘要

紫檀烷(AP)是黄芪根中的一种生物活性成分,被选为研究该化合物在体外代谢的模型化合物。其体外代谢是通过在含有 NADPH 生成系统的大鼠肝 9000g 上清液(S9)中孵育来进行的。首先,分离得到了四个化合物,并根据 NMR 数据分别将其结构解析为 6a-羟基-AP(M1)、紫檀林 I [M2,1a-羟基-9,10-二甲氧基-紫檀-1(2),4-二烯-3-酮]、9-去甲-AP(M3,尼索林)和 4-甲氧基-紫檀异黄酮(M4,7,2'-二羟基-4,3',4'-三甲氧基异黄酮)。其中,M1、M2 和 M4 是新化合物。接下来,通过 HPLC-DAD-ESI-IT-TOF-MS 获得了 AP 在大鼠肝 S9 中的代谢产物谱,并初步鉴定了 40 种新的代谢产物。这些新鉴定的代谢产物包括 9 种单羟基化代谢产物、1 种去甲基化代谢产物、7 种去甲基和单羟基化代谢产物、4 种二羟基化代谢产物、1 种水合代谢产物、1 种去二甲化代谢产物、2 种葡萄糖化代谢产物、1 种单羟基化和脱氢代谢产物、2 种单羟基化和去甲基化及脱氢代谢产物、2 种二聚化代谢产物、3 种二聚化和单羟基化代谢产物、2 种二聚化和去二甲化代谢产物以及 5 种二聚化和去甲基化代谢产物。最后,总结了 AP 在大鼠肝 S9 中的主要代谢反应,发现主要包括羟化、去甲基化、二聚化、水合和脱氢。更重要的是,首次报道了 AP 向 M2 的生物转化以及与肝 S9 孵育的 AP 二聚化。总之,这是首次在动物组织中对纯紫檀烷代谢的研究,这些发现将为进一步研究其他紫檀烷的代谢提供坚实的基础。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验